Clinical Trials in Forlì, Italy
15 recruiting
Showing 1–20 of 28 trials
Recruiting
Phase 3
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Progressive Pulmonary FibrosisInterstitial Lung Disease
United Therapeutics698 enrolled153 locationsNCT05943535
Recruiting
Phase 3
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
ObesityHeart Failure With Preserved Ejection FractionHeart Failure With Mildly Reduced Ejection Fraction
Amgen5,056 enrolled603 locationsNCT07037459
Recruiting
Phase 3
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
Progressive Pulmonary FibrosisIdiopathic Pulmonary Fibrosis
Boehringer Ingelheim1,700 enrolled371 locationsNCT06238622
Recruiting
Scaffold in Emilia Romagna and in the MAGIC Network
Coronary Artery Disease
University Hospital of Ferrara1,111 enrolled17 locationsNCT03327961
Recruiting
Phase 2
Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC
Metastatic Non-Squamous Non-Small Cell Lung CancerAdult Solid Tumor
CatalYm GmbH131 enrolled15 locationsNCT07246863
Recruiting
Phase 3
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Transthyretin Amyloidosis With Cardiomyopathy
Alnylam Pharmaceuticals1,250 enrolled207 locationsNCT07052903
Recruiting
Phase 2
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Prostate Cancer
Astellas Pharma Global Development, Inc.900 enrolled241 locationsNCT02960022
Recruiting
Phase 3
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
Primary MyelofibrosisPost-polycythemia Vera MyelofibrosisPost-essential Thrombocythemia Myelofibrosis
Swedish Orphan Biovitrum399 enrolled207 locationsNCT03165734
Recruiting
Not Applicable
Sexual Well-being of Women Undergoing Mastectomy and Reconstruction
Mastectomy and Breast ReconstructionSexual Wellness
European Institute of Oncology200 enrolled19 locationsNCT07234461
Recruiting
Upfront Targeted Axillary Dissection for Luminal Breast Cancer With Limited Axillary Involvement
Sentinel Lymph Node Biopsy (SLNB)ALNDTargeted Axillary Dissection (TAD)
European Institute of Oncology150 enrolled14 locationsNCT07278726
Recruiting
Acute Myocardial Infarction: Prognostic and Therapeutic Evaluation
Acute Coronary SyndromeMyocardium; Injury
IRCCS Azienda Ospedaliero-Universitaria di Bologna11,000 enrolled3 locationsNCT03883711
Recruiting
Microplastics and Nanoplastics in Patients With Chronic Coronary Syndromes
Pollution; ExposureMicroplasticsNanoplastics+4 more
Azienda Ospedaliera "Sant'Andrea"120 enrolled6 locationsNCT07291609
Recruiting
Phase 3
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
MyelofibrosisPrimary MyelofibrosisMF+2 more
Kartos Therapeutics, Inc.600 enrolled215 locationsNCT06479135
Recruiting
Microplastics and Nanoplastics (MNPs) in Patients With ST-elevation Myocardial Infarction (STEMI)
Pollution; ExposureST-elevation Myocardial Infarction (STEMI)Microplastics+1 more
Azienda Ospedaliera "Sant'Andrea"130 enrolled10 locationsNCT06965023
Recruiting
Health-care Quality in Semi-intensive Care Units
EvaluationSemi-intensive Care UnitQuality
Mario Negri Institute for Pharmacological Research39,000 enrolled25 locationsNCT04676347
Recruiting
Not Applicable
Transfemoral Transcatheter Aortic Valve Implementation at Hospital Without On-site Cardiac Surgery: Early Clinical Outcome in Patients With Prohibitive Surgical Risk.
Aortic Stenosis
AUSL Romagna Rimini200 enrolled4 locationsNCT05886517
Recruiting
Diagnosis and Outcomes of Placental Accretism
placenta accreta
IRCCS Azienda Ospedaliero-Universitaria di Bologna70 enrolled7 locationsNCT06833606
Recruiting
Visceral Leishmaniasis in Emilia-Romagna (Leishmania-2019)
Leishmaniasis, Visceral
IRCCS Azienda Ospedaliero-Universitaria di Bologna300 enrolled5 locationsNCT06793111
Recruiting
Not Applicable
What is the Best Interval to Screen Women 45-49 and 70-74 for Breast Cancer?
Breast Cancer
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS60,000 enrolled4 locationsNCT04590560
Recruiting
Phase 2Phase 3
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Endometrial Cancer
Kartos Therapeutics, Inc.268 enrolled83 locationsNCT05797831